Comparison of Intratympanic Steroid and Hyperbaric... (2023 study) Skip to main content
RCT Ear and hearing 2023

Comparison of Intratympanic Steroid and Hyperbaric Oxygen Salvage Therapy Hearing Outcomes in Idiopathic Sudden Sensorineural Hearing Loss: A Retrospective Study.

Ajduk J, Peček M, Kelava I, Žaja R, Ries M, Košec A, Ear and hearing, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked back at records of 126 people with sudden hearing loss whose first treatment with steroid medicine had not worked, and compared those who got steroid injections into the middle ear, those who got hyperbaric oxygen therapy, and those who got no further treatment.

What They Found

In this retrospective, nonrandomized cohort study of 126 people with sudden sensorineural hearing loss, both middle-ear steroid injections (ITS) and hyperbaric oxygen (HBO) therapy were associated with better hearing recovery than no second-line treatment, with average gains of 13.6 dB for ITS and 7.4 dB for HBO compared with the control group. Of the 126 patients, 43 received ITS, 35 received HBO, and 48 received no second-line therapy. The abstract reports that hearing improvement was statistically significant at all frequencies for both treatments. Having tinnitus (ringing in the ears) before treatment was linked to 4.67 dB less improvement on average. ITS was also linked to a larger reduction in tinnitus than the other two options.

What This Means for Canadian Patients

For people with sudden hearing loss who did not respond to oral steroids, this study found that HBO was associated with better hearing outcomes than observation alone. ITS was linked to larger hearing gains than HBO in this group. Because patients were not randomly assigned to treatments, the results show an association and do not prove that either treatment caused the improvement. Anyone considering these options should talk with their physician.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was retrospective and nonrandomized, so the groups may have differed in ways that affected the results, and the abstract does not report that the difference between ITS and HBO was tested directly.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 36693145
Year Published 2023
Journal Ear and hearing
MeSH Terms Humans; Retrospective Studies; Dexamethasone; Hyperbaric Oxygenation; Tinnitus; Cohort Studies; Salvage Therapy; Treatment Outcome; Hearing; Hearing Loss, Sudden; Hearing Loss, Sensorineural; Audiometry, Pure-Tone

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology